Creative Medical Technology Holdings, Inc.

NasdaqCM CELZ

Creative Medical Technology Holdings, Inc. Share Price on January 14, 2025: USD 2.15

Creative Medical Technology Holdings, Inc. Share Price is USD 2.15 on January 14, 2025, a -50.46% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.
  • Creative Medical Technology Holdings, Inc. 52-week high Share Price is USD 6.45 on March 11, 2024, which is 200.00% above the current Share Price.
  • Creative Medical Technology Holdings, Inc. 52-week low Share Price is USD 2.00 on December 19, 2024, which is -6.98% below the current Share Price.
  • Creative Medical Technology Holdings, Inc. average Share Price for the last 52 weeks is USD 3.81.
Key data
Date Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B)
Market news
Loading...
NasdaqCM: CELZ

Creative Medical Technology Holdings, Inc.

CEO Mr. Timothy Warbington
IPO Date Nov. 6, 2015
Location United States
Headquarters 211 East Osborn Road
Employees 4
Sector Health Care
Industries
Description

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

Similar companies

ATXI

Avenue Therapeutics, Inc.

USD 1.88

-1.05%

ICU

SeaStar Medical Holding Corporation

USD 1.91

-2.05%

VRAX

Virax Biolabs Group Limited

USD 2.29

-3.78%

PALI

Palisade Bio, Inc.

USD 1.75

-4.37%

SNGX

Soligenix, Inc.

USD 2.63

-15.97%

SONN

Sonnet BioTherapeutics Holdings, Inc.

USD 1.52

-3.80%

CDIO

Cardio Diagnostics Holdings, Inc.

USD 0.57

-9.14%

ADXN

Addex Therapeutics Ltd

USD 7.39

-3.40%

ZVSA

ZyVersa Therapeutics, Inc.

USD 1.49

12.03%

StockViz Staff

January 15, 2025

Any question? Send us an email